US 12,070,306 B2
Systems and methods for a continuous monitoring of analyte values
Jose Hector Hernandez-Rosas, San Diego, CA (US); Shawn Larvenz, Ramona, CA (US); Mark Dervaes, Carlsbad, CA (US); Indrawati Gauba, San Diego, CA (US); Michael Robert Mensinger, San Diego, CA (US); Eric Cohen, San Diego, CA (US); Brian Christopher Smith, San Marcos, CA (US); Jorge Valdes, Solana Beach, CA (US); and Jacob S. Leach, San Diego, CA (US)
Assigned to Dexcom, Inc., San Diego, CA (US)
Filed by Dexcom, Inc., San Diego, CA (US)
Filed on Jul. 5, 2023, as Appl. No. 18/347,048.
Application 18/347,048 is a continuation of application No. 17/806,933, filed on Jun. 14, 2022, granted, now 11,730,402.
Application 17/806,933 is a continuation of application No. 17/035,531, filed on Sep. 28, 2020, granted, now 11,399,742, issued on Aug. 2, 2022.
Application 17/035,531 is a continuation of application No. 16/694,900, filed on Nov. 25, 2019, granted, now 10,863,931, issued on Dec. 15, 2020.
Application 16/694,900 is a continuation of application No. 16/420,045, filed on May 22, 2019, abandoned.
Application 16/420,045 is a continuation of application No. 15/862,102, filed on Jan. 4, 2018, granted, now 10,335,065, issued on Jul. 2, 2019.
Application 15/862,102 is a continuation of application No. 14/533,943, filed on Nov. 5, 2014, granted, now 9,974,469, issued on May 22, 2018.
Claims priority of provisional application 61/901,358, filed on Nov. 7, 2013.
Prior Publication US 2023/0346267 A1, Nov. 2, 2023
Int. Cl. A61B 5/145 (2006.01); A61B 5/00 (2006.01); A61B 5/07 (2006.01); H04B 7/26 (2006.01); H04L 67/12 (2022.01); H04Q 9/00 (2006.01); H04Q 9/14 (2006.01); H04W 4/70 (2018.01); H04W 76/10 (2018.01); H04W 76/14 (2018.01); H04W 76/30 (2018.01); H04W 76/34 (2018.01)
CPC A61B 5/14503 (2013.01) [A61B 5/0004 (2013.01); A61B 5/076 (2013.01); A61B 5/14532 (2013.01); A61B 5/742 (2013.01); H04B 7/26 (2013.01); H04L 67/12 (2013.01); H04Q 9/00 (2013.01); H04Q 9/14 (2013.01); H04W 4/70 (2018.02); H04W 76/10 (2018.02); H04W 76/14 (2018.02); H04W 76/30 (2018.02); H04W 76/34 (2018.02); H04Q 2209/40 (2013.01); H04Q 2209/50 (2013.01)] 17 Claims
OG exemplary drawing
 
1. A passive medical system configured for wireless data communication with an analyte sensor system, the passive medical system comprising:
one or more memories for storing instructions and identification information associated with the analyte sensor system;
an insulin pump;
a wireless receiver configured to receive a wireless signal associated with an analyte value, wherein the analyte value is measured by the analyte sensor system; and
a processor operatively coupled to the one or more memories and the wireless receiver, wherein the processor is configured to execute the instructions to:
receive an advertisement signal from the analyte sensor system, wherein the advertisement signal comprises the analyte value measured by the analyte sensor system, and the advertisement signal is encrypted based on the identification information associated with the analyte sensor system so that a device that has the identification information can decrypt the analyte value;
extract the analyte value from the advertisement signal; and
perform a function associated with the insulin pump based on the extracted analyte value.